Advarra Achieves 1,000+ Site Milestone for its Gene Therapy Ready Network
Research involving gene therapy-based treatments can start more quickly with Advarra’s growing network of registered research sites.
Safe Sharps Handling When Dispensing Investigational Products
Care must be taken to avoid sharps-related injuries and exposures when preparing investigational products for clinic transportation.
Clean Bench vs Biosafety Cabinet: What’s the Difference?
Using hoods with biological materials depends on directional airflow, and specialized airflow is necessary when handling hazardous materials.
CBD Research: A Dive into the Regulations of Cannabis Research
With cannabis usage becoming more popular, there’s an uptick in research surrounding its therapeutic effects.
Does This Study Require IBC Review?
While clinical research professionals are familiar with the role of the IRB to protect research subjects, most are unfamiliar with the added need for an Institutional Biosafety Committee (IBC).
Reflections from Cell and Gene Meeting on the Mesa 2021
This blog recounts the 2021 Cell and Gene Meeting on the Mesa conference, including details on cell and gene therapy's growth and trajectory.
A Changing World in Gene Therapy Research: Exciting Opportunities for Medical Advancement and Biosafety Challenges
Our IBC experts authored the article “A Changing World in Gene Therapy Research: Exciting Opportunities for Medical Advancement and Biosafety...
James Riddle and Barbara Schneider Delve into the Different Players Involved in Reviewing Clinical Research
In this podcast episode, we discuss the different clinical research oversight committees and functions to ensure the safety of participants.
Why Institutions Should Consider an Externally Administered IBC
Gene therapy clinical trials require specialized oversight & expertise. Read how institutions can prep for the boom in gene therapy research.
Understanding the Current and Future States of Cell and Gene Therapy Research
This white paper focuses on gene therapy uses in oncology and looks at a successful program at an NCI-designated comprehensive cancer center.
Daniel Eisenman, Paul Gulig, and Adam Soloff Explore The Exponential Rise of Gene Therapy and Unlocking Its Potential Promise
In this podcast, Daniel Eisenmann talks with Adam Soloff and Paul Gulig for a discussion on the growth and the promise of gene therapy.
Q&A Part 1 – Gene Therapy Research in the Age of COVID-19
Panelists from Advarra’s inaugural virtual symposium participated in a Q&A session to address questions submitted by the audience. Read part 1: